Sep 13, 2022 / 01:00PM GMT
Jennifer Sadeghi - H.C. Wainwright & Co., LLC - Analyst
Good morning, everyone, and thank you for joining this presentation at the H.C. Wainwright 24th Annual Global Investment Conference. I'm Jennifer Sadeghi, and I'm an associate at H.C. Wainwright. I'd like to introduce our first presenter of Sernova Corp., Philip Toleikis, CEO and President. Hello.
Philip Toleikis - Sernova Corp. - President & CEO
Thank you. So welcome, everyone. And first, I would like to talk a little bit about our company's therapeutic approach. So we think about this many diseases are currently treated with drugs by masking symptoms and not really treating the actual disease. Another approach is to treat disease for patients who are missing certain factors from the body is to give them injections of the missing factor.
These treatments must be done on a daily basis or even multiple times a day for life. And if the patients don't take the drugs or factors, the disease is unmasked and returns again with serious side effects.
So what is Sernova doing? We're
Sernova Corp at H C Wainwright Global Investment Conference (Virtual) Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers